Interplay of cytokine polymorphisms and bacterial vaginosis in the etiology of preterm delivery

Journal of Reproductive Immunology

Volumn 87, Issue 1-2, 2010, Pages 82-89

  Jones, Nicole M ^a   Holzman, Claudia ^a   Friderici, Karen H ^b   Jernigan, Katherine ^b   Chung, Hwan ^a,c   Wirth, Julia ^a   Fisher, Rachel ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Ewha Womans University ^*  (United States)

^c Ewha Womans University   (South Korea)

Author keywords

Bacterial vaginosis; Gene environment interaction; IL 1 beta; Preterm birth; TNFalpha

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIAL VAGINOSIS; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; VAGINITIS;

EID: 78449281638     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2010.06.158     Document Type: Article

References (42)

1. Allsworth J.E., Peipert J.F. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet. Gynecol. 2007, 109:114-120.
2. Andrews W.W., Goldenberg R.L., Hauth J.C., Cliver S.P., Copper R., Conner M. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. Am. J. Obstet. Gynecol. 2006, 194:617-623.
3. Anum E.A., Springel E.H., Shriver M.D., Strauss J.F. Genetic contributions to disparities in preterm birth. Pediatr. Res. 2009, 65:1-9.
4. Arechavaleta-Velasco F., Ogando D., Parry S., Vadillo-Ortega F. Production of matrix metalloproteinase-9 in lipopolysaccharide-stimulated human amnion occurs through an autocrine and paracrine proinflammatory cytokine-dependent system. Biol. Reprod. 2002, 67:1952-1958.
5. Behrman R.E., Butler A.S. Committee on Understanding Premature Birth and Assuring Health Outcomes. Institute of Medicine (U.S.). Board on Health Sciences Policy., 2006. Preterm Birth: Causes, Consequences, and Prevention 2006, Institute of Medicine (U.S.), National Academies Press, Washington, DC.
6. Callaghan W.M., Macdorman M.F., Rasmussen S.A., Qin C., Lackritz E.M. The contribution of preterm birth to infant mortality rates in the United States. Pediatrics 2006, 118:1566-1573.
7. Edwards R.K., Ferguson R.J., Duff P. The interleukin-1 beta +3953 single nucleotide polymorphism: cervical protein concentration and preterm delivery risk. Am. J. Reprod. Immunol. 2006, 55:259-264.
8. El-Shazly S., Makhseed M., Azizieh F., Raghupathy R. Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes. Am. J. Reprod. Immunol. 2004, 52:45-52.
9. Engel S.A., Erichsen H.C., Savitz D.A., Thorp J., Chanock S.J., Olshan A.F. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 2005, 16:469-477.
10. Gargano J.W., Holzman C., Senagore P., Thorsen P., Skogstrand K., Hougaard D.M., et al. Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth. J. Reprod. Immunol. 2008, 79:100-110.
11. Genc M.R., Gerber S., Nesin M., Witkin S.S. Polymorphism in the interleukin-1 gene complex and spontaneous preterm delivery. Am. J. Obstet. Gynecol. 2002, 187:157-163.
12. Genc M.R., Vardhana S., Delaney M.L., Witkin S.S., Onderdonk A.B. TNFA-308G>A polymorphism influences the TNFalpha response to altered vaginal flora. Eur. J. Obstet. Gynecol. Reprod. Biol. 2007, 134:188-191.
13. Genc M.R., Witkin S.S., Delaney M.L., Paraskevas L.R., Tuomala R.E., Norwitz E.R., et al. A disproportionate increase in IL-1beta over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am. J. Obstet. Gynecol. 2004, 190:1191-1197.
14. Goepfert A.R., Goldenberg R.L., Andrews W.W., Hauth J.C., Mercer B., Iams J., et al. The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am. J. Obstet. Gynecol 2001, 184:483-488.
15. Hajeer A.H., Hutchinson I.V. TNFalpha gene polymorphism: clinical and biological implications. Microsc. Res. Tech. 2000, 50:216-228.
16. Hamilton, B.E., Martin, J., Ventura, S., Births: Preliminary Data for 2005. National Vital Statistics Reports, CDC, 2006.
17. Hedges S.R., Barrientes F., Desmond R.A., Schwebke J.R. Local and systemic cytokine levels in relation to changes in vaginal flora. J. Infect. Dis. 2006, 193:556-562.
18. Hernandez-Guerrero C., Monzon-Bordonaba F., Jimenez-Zamudio L., Ahued-Ahued R., Arechavaleta-Velasco F., Strauss J.F., et al. In-vitro secretion of proinflammatory cytokines by human amniochorion carrying hyper-responsive gene polymorphisms of tumour necrosis factor-alpha and interleukin-1beta. Mol. Hum. Reprod. 2003, 9:625-629.
19. Hitti J., Nugent R., Boutain D., Gardella C., Hillier S.L., Eschenbach D.A. Racial disparity in risk of preterm birth associated with lower genital tract infection. Paediatr. Perinat. Epidemiol. 2007, 21:330-337.
20. Holzman C., Bullen B., Fisher R., Paneth N., Reuss L., Group P.S. Pregnancy outcomes and community health: the POUCH study of preterm delivery. Paediatr. Perinat. Epidemiol. 2001, 15(Suppl. 2):136-158.
21. Holzman C., Leventhal J.M., Qiu H., Jones N.M., Wang J. Factors linked to bacterial vaginosis in nonpregnant women. Am. J. Public Health 2001, 91:1664-1670.
22. Holzman C., Lin X., Senagore P., Chung H. Histologic chorioamnionitis and preterm delivery. Am. J. Epidemiol. 2007, 166:786-794.
23. Kazzi S.N., Jacques S.M., Qureshi F., Quasney M.W., Kim U.O., Buhimschi I.A. Tumor necrosis factor-alpha allele lymphotoxin-alpha+250 is associated with the presence and severity of placental inflammation among preterm births. Pediatr. Res. 2004, 56:94-98.
24. Leitich H., Bodner-Adler B., Brunbauer M., Kaider A., Egarter C., Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am. J. Obstet. Gynecol. 2003, 189:139-147.
25. Leitich H., Brunbauer M., Bodner-Adler B., Kaider A., Egarter C., Husslein P. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am. J. Obstet. Gynecol. 2003, 188:752-758.
26. Macones G.A., Parry S., Elkousy M., Clothier B., Ural S.H., Strauss J.F. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am. J. Obstet. Gynecol. 2004, 190:1504-1508. discussion 1503A.
27. Menon R., Merialdi M., Betran A.P., Dolan S., Jiang L., Fortunato S.J., et al. Analysis of association between maternal tumor necrosis factor-alpha promoter polymorphism (-308), tumor necrosis factor concentration, and preterm birth. Am. J. Obstet. Gynecol. 2006, 195:1240-1248.
28. Menon R., Pearce B., Velez D.R., Merialdi M., Williams S.M., Fortunato S.J., et al. Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. Reprod. Biol. Endocrinol. 2009, 7:62.
29. Mitchell M.D., Edwin S., Romero R.J. Prostaglandin biosynthesis by human decidual cells: effects of inflammatory mediators. Prostaglandins Leukot. Essent. Fatty Acids 1990, 41:35-38.
30. Moore S., Ide M., Randhawa M., Walker J.J., Reid J.G., Simpson N.A. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG 2004, 111:125-132.
31. Ness R.B., Hillier S., Richter H.E., Soper D.E., Stamm C., Bass D.C., et al. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis?. J. Natl. Med. Assoc. 2003, 95:201-212.
32. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 1991, 29:297-301.
33. Oner C., Schatz F., Kizilay G., Murk W., Buchwalder L.F., Kayisli U.A., et al. Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. J. Clin. Endocrinol. Metab. 2008, 93:252-259.
34. Rauk P.N., Chiao J.P. Interleukin-1 stimulates human uterine prostaglandin production through induction of cyclooxygenase-2 expression. Am. J. Reprod. Immunol. 2000, 43:152-159.
35. Roberts A.K., Monzon-Bordonaba F., Van Deerlin P.G., Holder J., Macones G.A., Morgan M.A., et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am. J. Obstet. Gynecol. 1999, 180:1297-1302.
36. Romero R., Durum S., Dinarello C.A., Oyarzun E., Hobbins J.C., Mitchell M.D. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 1989, 37:13-22.
37. Sadowsky D.W., Adams K.M., Gravett M.G., Witkin S.S., Novy M.J. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am. J. Obstet. Gynecol. 2006, 195:1578-1589.
38. Savitz D.A., Dole N., Herring A.H., Kaczor D., Murphy J., Siega-Riz A.M., et al. Should spontaneous and medically indicated preterm births be separated for studying aetiology?. Paediatr. Perinat. Epidemiol. 2005, 19:97-105.
39. So T., Ito A., Sato T., Mori Y., Hirakawa S. Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. Biol. Reprod. 1992, 46:772-778.
40. Sturm-Ramirez K., Gaye-Diallo A., Eisen G., Mboup S., Kanki P.J. High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J. Infect. Dis. 2000, 182:467-473.
41. Wenstrom K.D., Andrews W.W., Hauth J.C., Goldenberg R.L., Dubard M.B., Cliver S.P. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am. J. Obstet. Gynecol. 1998, 178:546-550.
42. Zhang J., Savitz D.A. Preterm birth subtypes among blacks and whites. Epidemiology 1992, 3:428-433.